Crossmark

Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study

Crossref DOI link: https://doi.org/10.1038/gim.2018.44

Published Print: 2018-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Girardi, Fabio

Barnes, Daniel R.

Barrowdale, Daniel

Frost, Debra

Brady, Angela F.

Miller, Claire

Henderson, Alex

Donaldson, Alan

Murray, Alex

Brewer, Carole

Pottinger, Caroline

Evans, D Gareth

Eccles, Diana

Lalloo, Fiona

Gregory, Helen

Cook, Jackie

Eason, Jacqueline

Adlard, Julian

Barwell, Julian

Ong, Kai Ren

Walker, Lisa

Izatt, Louise

Side, Lucy E.

Kennedy, M John

Tischkowitz, Marc

Rogers, Mark T.

Porteous, Mary E.

Morrison, Patrick J.

Eeles, Ros

Davidson, Rosemarie

Snape, Katie

Easton, Douglas F.

Antoniou, Antonis C
License Information

Text and Data Mining valid from 2018-12-01

Text and Data Mining valid from 2018-12-01

Version of Record valid from 2021-11-24
More Information

This article is maintained by: Elsevier

Article Title: Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study

Journal Title: Genetics in Medicine

CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/gim.2018.44

Content Type: article

Copyright: © 2018, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics